Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 318098, 9 pages
http://dx.doi.org/10.1155/2014/318098
Research Article

IFN-γ-Secreting-Mesenchymal Stem Cells Exert an Antitumor Effect In Vivo via the TRAIL Pathway

1Department of Gynecology and Obstetrics, First Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an 710061, China
2Kingmed College of Laboratory Medicine, Guangzhou Medical University, Guangzhou 510182, China
3Department of Gastrointestinal-Pancreatic Surgery, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 51800, China

Received 10 March 2014; Revised 5 May 2014; Accepted 5 May 2014; Published 26 May 2014

Academic Editor: Yi Zhang

Copyright © 2014 Xinyuan Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. R. H. Lee, B. Kim, I. Choi et al., “Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue,” Cellular Physiology and Biochemistry, vol. 14, no. 4-6, pp. 311–324, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Klein, J. Strobel, J. Zingsem et al., “Ex vivo expansion of hematopoietic stem- and progenitor cells from cord blood in coculture with mesenchymal stroma cells from amnion, chorion, Wharton's jelly, amniotic fluid, cord blood, and bone marrow,” Tissue Engineering Part A, vol. 19, no. 23-24, pp. 2577–2585, 2013. View at Google Scholar
  4. K. Le Blanc and O. Ringdén, “Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation,” Biology of Blood and Marrow Transplantation, vol. 11, no. 5, pp. 321–334, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Le Blanc, I. Rasmusson, B. Sundberg et al., “Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells,” Lancet, vol. 363, no. 9419, pp. 1439–1441, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kidd, E. Spaeth, J. L. Dembinski et al., “Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging,” Stem Cells, vol. 27, no. 10, pp. 2614–2623, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Xu, L. Lin, G. Cao et al., “Interferon- α-secreting mesenchymal stem cells exert potent antitumor effect in vivo,” Oncogene, vol. 2013, article 458, 2013. View at Publisher · View at Google Scholar
  8. Y. Gao, A. Yao, W. Zhang et al., “Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice,” Oncogene, vol. 29, no. 19, pp. 2784–2794, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. K. McLean, Y. Gong, Y. Choi et al., “Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production,” Journal of Clinical Investigation, vol. 121, no. 8, pp. 3206–3219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. T. Lin, J. Y. Wang, M. K. Chen et al., “Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6,” Experimental Cell Research, vol. 319, no. 14, pp. 2216–2229, 2013. View at Google Scholar
  11. M. R. Moniri, X.-Y. Sun, J. Rayat et al., “TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells,” Cancer Gene Therapy, vol. 19, no. 9, pp. 652–658, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Du, L. Zhou, X. Chen et al., “IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand,” International Journal of Biochemistry and Cell Biology, vol. 44, no. 8, pp. 1305–1314, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Ke, P. Wang, W. Yu et al., “Derivation, characterization and gene modification of cynomolgus monkey mesenchymal stem cells,” Differentiation, vol. 77, no. 3, pp. 256–262, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Grisendi, R. Bussolari, L. Cafarelli et al., “Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy,” Cancer Research, vol. 70, no. 9, pp. 3718–3729, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Luo, S. Ok Lee, L. Liang et al., “Infiltrating bone arrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling,” Oncogene, vol. 2013, article 233, 2013. View at Publisher · View at Google Scholar
  16. S. Kidd, E. Spaeth, K. Watson et al., “Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma,” PLoS ONE, vol. 7, no. 2, Article ID e30563, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Zhu, Z. Sun, Q. Han et al., “Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1,” Leukemia, vol. 23, no. 5, pp. 925–933, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Sun, K.-H. Roh, J.-R. Park et al., “Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model,” Cytotherapy, vol. 11, no. 3, pp. 289–298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. R. S. Waterman, S. L. Tomchuck, S. L. Henkle, and A. M. Betancourt, “A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype,” PLoS ONE, vol. 5, no. 4, Article ID e10088, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. R. S. Waterman, S. L. Henkle, and A. M. Betancourt, “Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis,” PLoS ONE, vol. 7, no. 9, Article ID e45590, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Valente, L. Ozmen, F. Novelli et al., “Distribution of interferon-γ receptor in human tissues,” European Journal of Immunology, vol. 22, no. 9, pp. 2403–2412, 1992. View at Google Scholar · View at Scopus
  22. S. D. Der, A. Zhou, B. R. G. Williams, and R. H. Silverman, “Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 26, pp. 15623–15628, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. J. R. Jett, A. W. Maksymiuk, J. Q. Su et al., “Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer,” Journal of Clinical Oncology, vol. 12, no. 11, pp. 2321–2326, 1994. View at Google Scholar · View at Scopus
  24. J. H. Schiller, M. Pugh, J. M. Kirkwood, D. Karp, M. Larson, and E. Borden, “Eastern cooperative group trial of interferon gamma in metastatic melanoma: an innovative study design,” Clinical Cancer Research, vol. 2, no. 1, pp. 29–36, 1996. View at Google Scholar
  25. C. A. Kyriakou, K. L. Yong, R. Benjamin et al., “Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model,” Journal of Gene Medicine, vol. 8, no. 3, pp. 253–264, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. L. J. Chang and E. E. Gay, “The molecular genetics of lentiviral vectors–current and future perspectives,” Current Gene Therapy, vol. 1, no. 3, pp. 237–251, 2001. View at Google Scholar · View at Scopus
  27. M. R. Loebinger, A. Eddaoudi, D. Davies, and S. M. Janes, “Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer,” Cancer Research, vol. 69, no. 10, pp. 4134–4142, 2009. View at Publisher · View at Google Scholar · View at Scopus